1009 - Epigenetic and transcriptional single-cell profiling reveals CLL-like states in low-count MBL

Primary Author / Presenter(s)

Anja C. Rathgeber, MSc

Berlin Institute of Health @ Charité - Universitätsmedizin Berlin, Berlin, Germany; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany; Freie Universität Berlin, Department of Biology, Chemistry, Pharmacy, Berlin, Germany
Berlin, Germany

Co-Author(s)

SF

Stacey M. Fernandes, BS

Department of Medical Oncology, Dana-Farber Cancer Institute
Boston, Massachusetts, United States
AN

Adi Nagler, PhD

Department of Medical Oncology, Dana-Farber Cancer Institute
Boston, Massachusetts, United States
SL

Shuqiang Li, PhD

Translational Immunogenomics Lab, Dana-Farber Cancer Institute
Boston, Massachusetts, United States
DD

David M. Dorfman, MD, PhD

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School
Boston, Massachusetts, United States
LB

Lars Bullinger, PhD

Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin
Matthew S. Davids, MD, MMSc

Director, Clinical Research, Division of Lymphoma; Associate Professor of Medicine
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Jennifer R. Brown, MD, PhD

Director, CLL Center, and Institute Physician; Worthington Margaret Collette Professor of Medicine in the Field of Hematologic Oncology
Dana-Farber Cancer Institute, Harvard Medical School
Boston, Massachusetts, United States
KL

Kenneth J. Livak, PhD

Department of Medical Oncology, Dana-Farber Cancer Institute; Translational Immunogenomics Lab, Dana-Farber Cancer Institute
Boston, Massachusetts, United States
LL

Leif S. Ludwig, MD

Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany
Berlin, Germany
Catherine Wu, MD

Professor of Medicine
Dana-Farber Cancer Institute, Harvard Medical School
Boston, Massachusetts, United States
Livius Penter, MD

Postdoctoral Research Fellow
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA ; Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité - Universitätsmedizin; Berlin Institute of Health at Charité – Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Digital Clinician Scientist Program, Berlin, Germany
Berlin, Germany